Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Colorectal Neoplasms

Free Subscription 18.08.2025 1 Ann Surg 1 Ann Surg Oncol 1 BMC Cancer 7 BMC Gastroenterol 1 Br J Surg 1 Cancer 2 Cancer Lett 1 Dis Colon Rectum 2 Eur J Cancer 1 Eur J Gastroenterol Hepatol 1 Int J Colorectal Dis 2 Lancet Oncol 1 Oncol Rep 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg

1. SHIGETA K, Mizuno S, Orgun D, Kato Y, et al
   International Validation of a Recurrence Risk Model for Stage II Colon Cancer: The SPHERE Study.
   Ann Surg. 2025 Aug 13. doi: 10.1097/SLA.0000000000006911.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. LIU D, Cai J
   Reply to: "An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer", by Mo et al.
   Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18048.
   PubMed        
   
   

   
   BMC Cancer

3. BAI M, Liu L, Liu M, Liu X, et al
   Impact of preoperative abdominal MRI staging on outcomes for stage II-III colon cancer: a propensity score-matched cohort study.
   BMC Cancer. 2025;25:1283.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

4. CHIU DW, Rashad N, Kordy N, Shash E, et al
   Epidemiologic and clinical profiles of colorectal cancer in Southern Egypt.
   BMC Gastroenterol. 2025;25:569.
   PubMed         Abstract available
   
   
5. LUO S, Gong J, Zhu Y, Wang L, et al
   Global, regional, and national burden of colorectal cancer in the elderly (aged > 60 years): a comprehensive analysis across 204 countries and territories (1990-2021)?.
   BMC Gastroenterol. 2025;25:570.
   PubMed         Abstract available
   
   
6. LAI B, Li Z, Li J
   Cruciferous vegetables intake and risk of colon cancer: a dose-response meta-analysis.
   BMC Gastroenterol. 2025;25:575.
   PubMed         Abstract available
   
   
7. LIAO X, Liu M, Hong C, Liu Y, et al
   Overexpression of Protein Kinase C iota as a prognostic marker and its role in oxaliplatin resistance in colorectal cancer.
   BMC Gastroenterol. 2025;25:580.
   PubMed         Abstract available
   
   
8. WANG Y, Ding L, Ji L, Yan Z, et al
   The value of systemic inflammatory response index in evaluating the prognosis of postoperative patients with stage II colon cancer.
   BMC Gastroenterol. 2025;25:581.
   PubMed        
   
   
9. HATAMINEJAD M, Basirpour B, Baharlou M, Gholami Koohestan M, et al
   Global prevalence and correlation of intestinal parasitic infections in patients with colorectal cancer: a systematic review and meta-analysis.
   BMC Gastroenterol. 2025;25:584.
   PubMed         Abstract available
   
   
10. FUJII T, Hirasaki M, Kamakura Y, Kawasaki T, et al
    Evaluation of PINK1 protein expression as a predictive marker for the efficacy of adjuvant chemotherapy in colorectal cancer: a retrospective study.
    BMC Gastroenterol. 2025;25:582.
    PubMed         Abstract available
    
    

    
    Br J Surg

11. VU JK, Brown KGM, Solomon MJ, Ng KS, et al
    Patterns and outcomes of disease recurrence after pelvic exenteration for locally recurrent rectal cancer.
    Br J Surg. 2025;112:znaf154.
    PubMed         Abstract available
    
    

    
    Cancer

12. TANGKA FKL, Ruiz E, Ibarra R, Hudson SM, et al
    Effectiveness and cost of implementing a patient navigation program to increase colorectal cancer screening in a large federally qualified health center.
    Cancer. 2025;131:e70031.
    PubMed         Abstract available
    
    

    
    Cancer Lett

13. HORN DM, Phillips KA, Schulman KA
    Comparison of Food and Drug Administration Expedited Approvals and Guideline Updates: A Case Study of Immune Checkpoint Inhibitors in Colon Cancer Care.
    Cancer Lett. 2025 Aug 12:217979. doi: 10.1016/j.canlet.2025.217979.
    PubMed        
    
    
14. TSAI HY, Chen MH, Yun J, Lai LA, et al
    Restricting metabolic plasticity enhances stress adaptation through the modulation of PDH and HIF1A in TRAP1-depleted colon cancer.
    Cancer Lett. 2025 Aug 9:217977. doi: 10.1016/j.canlet.2025.217977.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

15. SRIKUMAR G, McLaughlin SJP, Jebbink J, Hwang N, et al
    How Frequently Is Colorectal Cancer Recurrence Detected in Clinic?
    Dis Colon Rectum. 2025 Aug 11. doi: 10.1097/DCR.0000000000003934.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

16. ITALIANO A, Gautier O, Dupont J, Assi T, et al
    The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients.
    Eur J Cancer. 2025;226:115609.
    PubMed         Abstract available
    
    
17. HAN L, Josephs D, McDonald L, Gomm L, et al
    The effect of centralising novel cell therapies for solid cancers - a health systems planning model for Europe.
    Eur J Cancer. 2025;226:115594.
    PubMed         Abstract available
    
    

    
    Eur J Gastroenterol Hepatol

18. TARIQ MA, Asrar A, Amin H
    Colorectal cancer mortality among Asian Americans: a disaggregated analysis from 2018 to 2023.
    Eur J Gastroenterol Hepatol. 2025;37:1088-1090.
    PubMed        
    
    

    
    Int J Colorectal Dis

19. ZHENG L, Zhang X, Ma B, Yuan Y, et al
    Efficacy of non-pharmacological interventions for the restoration of postoperative intestinal motility of patients with colorectal cancer: a systematic review and meta-analysis of randomized controlled trials.
    Int J Colorectal Dis. 2025;40:176.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

20. JENSEN LH
    Breaking the patient-reported outcome code in KRAS(G12C)-mutated colorectal cancer: clinical interpretation of CodeBreaK 300.
    Lancet Oncol. 2025 Aug 11:S1470-2045(25)00411.
    PubMed        
    
    
21. MODEST DP, Fakih M, Salvatore L, Esaki T, et al
    Health-related quality of life in patients with KRAS(G12C)-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial.
    Lancet Oncol. 2025 Aug 11:S1470-2045(25)00352.
    PubMed         Abstract available
    
    

    
    Oncol Rep

22. HE Y, Luo C, Du W, Liu D, et al
    Circular RNAs in colorectal cancer: From molecular mechanisms to therapeutic applications (Review).
    Oncol Rep. 2025;54:139.
    PubMed         Abstract available
    
    

    
    PLoS One

23. KHATRI RB, Endalamaw A, Darssan D, Assefa Y, et al
    A scoping review of the levels, implementation strategies, enablers, and barriers to cervical, breast, and colorectal cancer screening among migrant populations in selected English-speaking high-income countries.
    PLoS One. 2025;20:e0329854.
    PubMed         Abstract available
    
    
24. LEE Y, Silva SG, Gonzalez-Guarda RM
    Social determinants of health, health behaviors, and general health among colorectal cancer survivors: A cross-sectional study.
    PLoS One. 2025;20:e0329752.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.